Expression of EZH2 is associated with poor outcome in colorectal cancer

Enhancer of zeste homolog 2 (EZH2), the critical component of polycomb group protein family, has been demonstrated to be overexpressed in various types of human cancer, including hepatocellular carcinoma, breast, bladder and lung cancer. The mechanism of how EZH2 promotes oncogenesis has also been w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhuanpeng, Yang, Ping, Li, Wanglin, He, Feng, Wei, Jianchang, Zhang, Tong, Zhong, Junbin, Chen, Huacui, Cao, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778885/
https://www.ncbi.nlm.nih.gov/pubmed/29435024
http://dx.doi.org/10.3892/ol.2017.7647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778885/
https://www.ncbi.nlm.nih.gov/pubmed/29435024
http://dx.doi.org/10.3892/ol.2017.7647

Ejemplares similares